Certara, Inc. (CERT)
NASDAQ: CERT · Real-Time Price · USD
10.86
-0.31 (-2.78%)
Aug 14, 2025, 11:51 AM - Market open
Certara Revenue
Certara had revenue of $104.57M in the quarter ending June 30, 2025, with 12.06% growth. This brings the company's revenue in the last twelve months to $405.76M, up 11.61% year-over-year. In the year 2024, Certara had annual revenue of $385.15M with 8.70% growth.
Revenue (ttm)
$405.76M
Revenue Growth
+11.61%
P/S Ratio
4.43
Revenue / Employee
$262,455
Employees
1,546
Market Cap
1.74B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 385.15M | 30.81M | 8.70% |
Dec 31, 2023 | 354.34M | 18.69M | 5.57% |
Dec 31, 2022 | 335.64M | 49.54M | 17.32% |
Dec 31, 2021 | 286.10M | 42.57M | 17.48% |
Dec 31, 2020 | 243.53M | 35.02M | 16.79% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 422.82B |
Johnson & Johnson | 90.63B |
Merck & Co. | 63.62B |
AbbVie | 58.33B |
AstraZeneca | 56.50B |
Novartis AG | 55.19B |
Eli Lilly and Company | 53.26B |
Novo Nordisk | 49.11B |
CERT News
- 7 days ago - Certara, Inc. (CERT) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Certara Reports Second Quarter 2025 Financial Results - GlobeNewsWire
- 10 days ago - Certara Simcyp® Simulator Becomes First and Only Software Platform to Receive EMA Qualification Opinion for PBPK Modeling - GlobeNewsWire
- 13 days ago - Certara Appoints Dr. Chris Bouton as Chief Technology Officer to Advance AI in-silico Drug Discovery and Development Platform - GlobeNewsWire
- 4 weeks ago - Certara: Ideally Positioned To Benefit From IT Innovation In Life Sciences - Seeking Alpha
- 5 weeks ago - Certara to Report Second Quarter 2025 Financial Results on August 6th, 2025 - GlobeNewsWire
- 5 weeks ago - Certara Announces Expansion of Clinical Technology Collaboration with Merck - GlobeNewsWire
- 3 months ago - Certara, Inc. (CERT) Q1 2025 Earnings Call Transcript - Seeking Alpha